Opening Remarks
Chairperson：
Advanced Cell Therapies in the COVID-19 Pandemic/post-Pandemic Era.

Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.
 

Section1  Moderator：

Dr. Chang-Yao Tsao / MD, PhD, Professor.
Internal of Medicine, Director, Immune Cell Therapy Unit,Chung Shan Medical University, Taichung, Taiwan.

Human Umbilical Cord-Derived Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome.

Dr.Hon-Kan Yip/Professor Level Attending Physician.
Kaohsiung Chang Gung Memorial Hospital, Taiwan.

Mesenchymal stem cell therapy for severe COVID-19: Sharing experience from Thailand

Dr. Sithakom Phusanti
Deputy Director and Chief of Information Officer (CIO)/ Physician (Hematologist, Internist)
Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Thailand.

Applications of mesenchymal stem cells in immune disorders and lung injury, including severe COVID-19 infection.

Dr. Kang-Hsi Wu/ MD, Vice superintendent.
Chung Shan Medical University Hospital, Taichung, Taiwan.

Umbilical cord mesenchymal stromal cell as critical COVID-19 adjuvant therapy.

Professor Ismail H Dilogo/ MD, PhD.
Stem Cell Medical Technology Integrated Service Unit, Cipto
Mangunkusumo Central Hospital, Faculty of Medicine University Indonesia, Jakarta, Indonesia.

Section1 Panel Discussion

Moderator: Dr. Chang-Yao Tsao
Panelists: Dr.Hon-Kan Yip/Dr. Sithakom Phusanti/Dr. Kang-Hsi Wu/Professor Ismail H Dilogo

Section2 Moderator：

Dr. Tokiko Nagamura-Inoue / MD, PhD, Hospital professor.
Research hospital, Inst. of Medical Science, Univ. of Tokyo, Japan.

The promise of cell therapy for pediatric acute/chronic lung disease: clinical case sharing.

Dr. Pei-Chen Tsao/ Director of neonatal intensive care unit.
Taipei Veterans General Hospital, Taiwan.

Stem Cells Technology 4.0 in Anti-Ageing and Anti-COVID

Professor Phan Toan-Thang / Founding Director and Chief Scientific Officer
Cell Research Corporation, Singapore.

The anti-inflammatory and Immunomodulatory actions of human umbilical cord derived mesenchymal stem cells: Clinical Perspectives.

Dr. Chin Sze-Piaw / Clinical and Research Advisor
CYTOPEUTICS & Honorary Fellow of the Centre for Stem Cell Research (CSCR), Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman (UTAR), Malaysia.

Section2 Panel Discussion/ Final Conclusions

Moderator: Dr. Tokiko Nagamura-Inoue
Panelists: Dr. Pei-Chen Tsao/Dr. Ivor Lim/Dr. Chin Sze-Piaw
Organizer: Chris Tsai-Chairman of BIONET Corp. /Dr. Wen-Chien Lee- President of Asian Federation of Biotechnology.